Antimicrobial Resistance in Livestock and Food - Its Significance for Human Medicine and Options for Action in Risk Management by German Federal Institute for Risk Assessment
 Page 1 of 4 
www.bfr.bund.de 
Antimicrobial Resistance in Livestock and Food - Its Significance for Human 
Medicine and Options for Action in Risk Management 
 
BfR Communication No. 003/2015 dated 22 January 2015 
 
Bacteria which are resistant to antimicrobial substances (antibiotics) are widespread. These 
bacteria are selected by the use of antibiotics. In the presence of antibiotics, they have ad-
vantages over their competitors without resistance properties and can multiply faster and 
more strongly. This is true in livestock as well as people. It becomes a problem when the 
bacteria in question are pathogenic.  
 
The Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR) has 
evaluated the significance of these resistances in livestock and in food for human consump-
tion. The BfR concludes that the assessment of the contribution made by antimicrobial re-
sistance in livestock that may be transmitted to humans through food to the extent of antimi-
crobial resistance in human medicine varies according to the bacteria and type of resistance.  
 
In the case of multi-resistant Staphylococcus aureus (MRSA) bacteria, the strains originating 
from animals (livestock-associated MRSA) are currently of minor importance for infections in 
humans with the exception of people who have frequent contact with livestock (farmers, vet-
erinarians, farm workers. The latter can be carriers of livestock-associated MRSA. These 
people should be tested to determine whether they are carriers of MRSA prior to treatment 
with antibiotics, surgery or admission to a clinic, 
 
The situation is assessed differently when it comes to ESBL/AmpC-producing strains of bac-
teria. These resistances severely impair treatment with 3rd and 4th generation cephalosporins, 
which are used to combat a variety of bacterial infections. The resistant strains of bacteria 
such as Escherichia coli, Klebsiella and Citrobacter are a cause of concern because the re-
sistance genes are located in mobile genetic elements. They can be easily transferred and 
recombined among these and other pathogenic bacteria. This transfer is increased with anti-
biotic treatment. Since these bacteria occur both in humans and in animals, such resistances 
are equally problematic in the treatment of livestock and the treatment of humans. Preventive 
measures to counter their prevalence should be taken on livestock farms as well as in human 
medicine.  
 
Initial analyses quantifying the significance of livestock as a reservoir for ESBL-producing 
E. coli in Germany show that the most common ESBL genes occur in isolates of humans as 
well as various animal species. This substantiates previous findings that animals play a role 
as a source of such bacteria or resistance genes. In addition to direct transfer of the bacteria, 
the fact that resistance genes can be transferred to other bacteria is of particular importance 
here.  
 
For this reason, only a joint preventive control strategy of veterinary and human medicine 
(one health approach) against the spread of resistant pathogens can be successful.  
 
Bacteria that are resistant to antimicrobial substances including multi-resistant strains are 
widespread and are selected by the use of antibiotics. However, a large number of factors 
with complex interrelations contribute to the spread of these pathogens. The relationship 
between livestock farming and consumer health protection with respect to antimicrobial re-
sistance needs to be analysed in view of this complexity.  
 
   Page 2 of 4 
www.bfr.bund.de 
Bundesinstitut für Risikobewertung 
There are considerable problems with antimicrobial resistance, both in human and veterinary 
medicine. However, these problems only partially share the same origin. Moreover, the ex-
tent of this common resistance problem and the transmission paths between the animal and 
human population differ depending on the bacteria in question.  
 
Methicillin-resistant Staphylococcus aureus (MRSA) 
 
For example, methicillin-resistant Staphylococcus aureus (MRSA) from livestock (la-MRSA) 
plays a minor role as a pathogen causing difficult-to-treat infections in humans compared to 
MRSA types from humans (community- and hospital-acquired MRSA). In total, la-MRSA ac-
count for less than 5% of all detected and typified MRSA in humans. They are mostly detect-
ed in people who are exposed to livestock in their working life, such as farmers and veteri-
narians. Conversely, this means that 95% of detected MRSA in humans originates from the 
field of human medicine. As la-MRSA are mostly sensitive to other therapeutically significant 
classes of antimicrobials, it is usually possible to treat these infections.  
 
To date, there has been little evidence of MRSA being transmitted to people through food. 
The risk of MRSA being transmitted to people through food is currently assessed as low. 
Risks could arise from direct contact of injured skin with the pathogen or manual transfer to 
wounds at other body sites. Adherence to kitchen hygiene rules is important here. In princi-
ple, MRSA CC398 (la-MRSA) can be detected in most illness types associated with S. aure-
us, i.e. from wound infections to pneumonia and septicaemia. In regions with a high livestock 
density, the proportion of la-MRSA among all MRSA in humans may be significantly higher 
than in regions with a low livestock density. 
 
ESBL/AmpC-producing strains of bacteria 
 
The resistance problem through ESBL/AmpC-producing bacteria shared by human and vet-
erinary medicine is more significant problem than with MRSA. 3rd and 4th generation cepha-
losporins are important in the treatment of a large number of infections. For this reason, this 
resistance greatly restricts treatment options in the event of an infection. The mobility of the 
underlying resistance mechanisms represents an additional challenge. Intestinal bacteria 
such as Escherichia coli, Klebsiella and Citrobacter, which occur frequently in both humans 
and animals, can transfer their resistance properties to one another. This means that differ-
ent properties can be combined and dangerous pathogens can result from these recombina-
tions which could be problematic in both humans and animals in the event of an infection 
requiring treatment.  
 
Consumers can be exposed to these pathogens through food, but also through direct contact 
with animals. Human-to-human transmission in hospitals and in the general population also 
plays a significant role in the spread of ESBL-producing bacteria.  
 
People can be colonised, for instance, through the consumption of food contaminated with 
ESBL-producing bacteria. The significance of this transmission path is difficult to assess. 
The risk of colonisation and infection of people via food depends among others on the quan-
tity of these bacteria in the food. The question of whether the pathogen can multiply in the 
food contributes to the pathogen quantity. Kitchen hygiene during food preparations is an 
additional factor.  
 
Initial analyses attempting to quantify the significance of livestock as a reservoir for ESBL-
producing E. coli to humans in Germany show that the most common ESBL genes occur in 
isolates of both humans and animals. However, the proportions of these genes in ESBL-
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producing E.coli isolates of animals and humans differ substantially. This substantiates pre-
vious findings that animals play a role as a source of such bacteria or resistance genes. At 
the same time, these studies elucidated that the same resistance genes occur in all observed 
groups of livestock, i.e. that not only poultry plays a role as a reservoir. Currently, the vast 
majority of colonisations of humans with ESBL-producing E. coli cannot be directly explained 
by exposure to livestock farming or food-producing animals. In addition to direct transmission 
of bacteria, there is also the possibility that these bacteria merely act as a vehicle from ani-
mals to humans. The resistance genes are then transferred to other bacteria in the human 
body. In this case, it is often difficult to trace the transmission path because the bacteria 
causing the infection and the resistance gene have different sources.  
 
Recommendation for consumers on preparing meat 
 
For protection again MRSA and ESBL-producing bacteria, consumers should adhere to the 
same hygiene rules that apply to other pathogens that can be transferred to humans from 
animals or from food. These rules include the following:  
 
 After contact with animals, wash your hands with warm water and soap. This also ap-
plies to contact with household pets.  
 
 Wash your hands thoroughly with soap and water before and after preparing raw 
meat. 
 
 Where possible, avoid touching animals and raw meat with your mouth. 
 
 Make sure that food, particularly meat and eggs, is fully cooked before consumption. 
 
 Wash uncooked fruit and vegetables, such as lettuce and sprouts, thoroughly with 
drinking water before consumption and peel fruit and vegetables. 
 
 Prevent raw meat or eggs from coming into direct or indirect contact with prepared 
food that will not be heated up again. Adhere strictly to the relevant hygiene rules for 
storing and preparing food in order to keep the bacterial count as low as possible. 
 
You can protect yourself and others from infections by observing hygiene rules in order to 
prevent the transmission of bacteria to other food and by cooking poultry thoroughly before 
consumption.   
 
The BfR has provided additional tips in the leaflet “Protection against food infections in pri-
vate households”:  
 
http://www.bfr.bund.de/cm/350/verbrauchertipps_schutz_vor_lebensmittelinfektionen_im_priv
athaushalt.pdf 
 
Action required in livestock farming 
 
From the veterinary point of view, the following action is required in livestock farming:  
 
1. The selection pressure in the direction of resistant bacteria should be reduced. Methods 
for this include: 
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 Improving animal health, for example by means of zootechnical measures, optimised 
feeding, hygiene and management, and targeted evidence-based treatment of infec-
tious diseases actually requiring treatment are necessary.   
 
 Systematic recording of the use of antibiotics in livestock farming, which was intro-
duced with the 16th amendment of the German Drug Act (AMG), results in an im-
portant measure for the success of the reduction strategies. 
 
 One important component of any reduction strategy is the systematic evaluation of 
this data in order to detect the main problem areas and address them in a targeted 
manner. 
 
2. The transmission of resistant bacteria from animals to people and from the health system 
to livestock should be reduced through a variety of measures: 
 
 In the area of food production, the spread of bacteria along the chain to the consumer 
should be avoided. This requires further improvements in slaughterhouse hygiene.  
 
 Consumers should carefully select food and ensure adequate kitchen hygiene in or-
der to prevent infection with existing bacteria. 
 
 More efficient technology for minimising emissions containing bacteria from livestock 
farming should be developed. 
 
 Because of intensive contact with animals, veterinarians and farmers constitute po-
tential sources for the entry of resistant pathogens into the healthcare system. For 
this reason, the Hospital Hygiene Commission at the Robert Koch Institute has issued 
the following recommendation since 2008: persons belonging to these groups should 
be subjected to routine screening for MRSA before admission to a hospital or senior 
citizens’ home.  
 
The challenges posed by the development of antimicrobial resistance are complex and need 
to be tackled jointly by veterinary and human medicine (one health approach). Best practice 
examples should be developed and communicated. Interdisciplinary research projects in 
which the BfR is involved (e.g. MedVetStaph, RESET) contribute to further important findings 
for understanding the common resistance problem.  
